TPCW
SRTAW

TD Private Client Wealth’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

TD Private Client Wealth’s Portfolio SRTAW Stock Details SRTAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-600
Closed -$246 – 1422
2024
Q4 		$246 Hold
600
– – ﹤0.01% 1291
2024
Q3 		$114 Hold
600
– – ﹤0.01% 1269
2024
Q2 		$101 Hold
600
– – ﹤0.01% 1206
2024
Q1 		$63 Hold
600
– – ﹤0.01% 1210
2023
Q4 		$210 Hold
600
– – ﹤0.01% 1212
2023
Q3 		$138 Buy
+600
New +$282 ﹤0.01% 1209

Other funds holding SRTAW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TD Private Client Wealth's SRTAW Position: Q1 2025 in Review

TD Private Client Wealth sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2025, closing a stake of 600 shares — an estimated $246 sold.

TD Private Client Wealth first reported a position in SRTAW in Q3 2023 and held it in 6 quarters. The position peaked at $246 in Q4 2024. 6 funds tracked by Wall St. Rank hold SRTAW as of Q1 2025.

  • TD Private Client Wealth reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2025 after selling out during the quarter.
  • TD Private Client Wealth sold 600 Strata Critical Medical Inc Warrants shares in Q1 2025, an estimated $246.
  • TD Private Client Wealth first reported a position in Strata Critical Medical Inc Warrants in Q3 2023 and held it in 6 quarters.
  • TD Private Client Wealth's Strata Critical Medical Inc Warrants position peaked at $246 in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2025.

Based on TD Private Client Wealth's 13F filing for Q1 2025, filed 29 Apr 2025.